Palantir Results Presentation Deck

Q2 Business Update Novartis CEO Vas Narasimhan names partnership with Palantir as key accelerator for pharmaceutical R&D. 66 We have one fundamental advantage versus our peers: five years ago, we created an integrated data lake we called data42 with our partners at Palantir. 66 We're using that data lake to move Al very quickly forward in the company... our data is organized, it has a clear Ontology, and I'm hoping that will lead to more discoveries faster over time. Watch the entire interview on © 2023 Palantir Technologies Inc. CNBC 184 101.40 104.30 106 NOVAR 301.79 & NOVARTIS SQUAWKON HEALTHCARE AND AI NOVARTIS CEO ON R&D SUPPORT THE STREET SQ THE CNBC

View entire presentation